Vintage Biological Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 1.80 M
- Revenue Growth -41.81%
- Profit Growth -745.74%
- Ebitda -328.86%
- Net Worth -46.35%
- Total Assets -33.43%
About Vintage Biological
Vintage Biological Private Limited (VBPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 April 2012 and has a history of 12 years and nine months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹1.80 M.
Laxminarayan Galagali, Niraj Dubey, and Vishnu Dayal serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51101PN2012PTC145412
- Company No.
145412
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2012
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Vintage Biological?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishnu Dayal  | Director | 30-Apr-2012 | Current |
| Laxminarayan Galagali | Director | 30-Apr-2012 | Current |
| Niraj Dubey | Director | 19-Aug-2013 | Current |
Financial Performance of Vintage Biological.
Vintage Biological Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 41.81% decrease. The company also saw a substantial fall in profitability, with a 745.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vintage Biological?
In 2017, Vintage Biological had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.80 M
₹0
Charges Breakdown by Lending Institutions
- Vijaya Bank : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Nov 2014 | Vijaya Bank | ₹1.80 M | Open |
How Many Employees Work at Vintage Biological?
Vintage Biological has a workforce of 22 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vintage Biological, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vintage Biological's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
